Skip to main content
Premium Trial:

Request an Annual Quote

Decode Shares Hit 52-Week High on Diabetes Gene Discovery

NEW YORK, Jan. 17 (GenomeWeb News) - Shares of Decode Genetics hit a 52-week high in trading today after the company's weekend announcement that it had discovered a variation of a gene that heightens the risk of type 2 diabetes.


Decode's stock price rose $1.39, or almost 15 percent, to a high of $10.77 in morning trading before retreating back below $10. The shares were trading up 5.97 percent, or $.56, at $9.94 in late-afternoon trading.


On Sunday the Reykjavik-based company said it had discovered a variant in a gene on chromosome 10 that raises the risk of adult onset diabetes.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.